Catalog No.
Product Name
Application
Product Information
Citations
-
Purine Nucleoside Analog
1,2-Di-O-acetyl-3,5-di-O-benzoyl-3-beta-C-methyl-D-ribofuranose serves as a purine nucleoside analog, primarily targeting DNA synthesis inhibition. This compound exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its mechanisms of action include the induction of apoptosis and disruption of cellular proliferation, making it a valuable reagent for cancer research applications. -
Purine Nucleoside Analog
4-Hydroxy-1-(2,3,5-tri-O-benzoyl-β-D-ribofuranosyl)-2(1H)-pyridinone is a purine nucleoside analog primarily targeting DNA synthesis pathways. This compound exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its anticancer effects are attributed to mechanisms such as the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable reagent for research in cancer biology and therapeutic development. -
Purine Nucleoside Analog
2-Chloro-3'-deoxy-3'-fluoroadenosine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its mechanisms include the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool for cancer research. This compound can be utilized in studies aiming to understand nucleoside analog effects and therapeutic strategies for hematological cancers. -
Purine Nucleoside Analog
3'-O-(t-Butyldimethylsilyl)-2'-deoxy-2'-fluorouridine is a purine nucleoside analog that exhibits significant antitumor activities. It primarily functions by inhibiting DNA synthesis and promoting apoptosis in various cancer cell types, making it especially relevant for research involving indolent lymphoid malignancies. This compound serves as a valuable tool for studying cancer biology and the development of targeted therapeutics. -
Purine Nucleoside Analog
1,2-Di-O-isopropylidene-3-O-methyl-D-ribofuranose is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its mechanisms of action involve the inhibition of DNA synthesis and the induction of apoptosis in cancer cells. This compound is valuable for research applications aimed at understanding cancer cell metabolism and therapeutics. -
Purine Nucleoside Analog
2-Amino-6-chloro-9-(3-deoxy-beta-D-ribofuranosyl)-9H-purine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its mode of action involves the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool for cancer research and therapeutic studies. This compound is ideal for investigations into the mechanisms of tumorigenesis and the development of novel anticancer strategies. -
Purine Nucleoside Analog
5′-Azido-2′,5′-dideoxy-2′-fluorouridine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its anticancer properties are primarily attributed to the inhibition of DNA synthesis and the induction of apoptosis. Additionally, this compound serves as a versatile click chemistry reagent, featuring an azide group that facilitates copper-catalyzed azide-alkyne cycloaddition (CuAAc) and strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with alkyne-containing molecules or reactive DBCO/BCN groups, respectively. These characteristics make it a valuable tool for various research applications in chemical biology and drug development. -
Adenosine Analog
2′-β-C-Methyl-2-methoxyadenosine is an adenosine analog that primarily targets adenosine receptors. This compound exhibits vasodilatory effects on smooth muscle and has demonstrated potential in inhibiting cancer progression. Its applications extend to research involving cardiovascular function and cancer biology, making it a valuable tool for exploring therapeutic strategies in these areas. -
Purine Nucleoside Analog
3’-β-Amino-2’,3’-dideoxy-5’-O-trityl-5-methyl uridine is a purine nucleoside analog that exhibits significant antitumor activity, particularly in indolent lymphoid malignancies. Its primary mechanism involves the inhibition of DNA synthesis, contributing to the induction of apoptosis in cancer cells. This reagent is valuable for research applications focused on cancer biology and therapeutic development. -
Purine Nucleoside Analog
5-(2,3,5-Tri-O-benzyl-beta-D-ribofuranosyl)-3-methyl-2-benzyloxypyridine is a purine nucleoside analog that demonstrates significant antitumor activity against indolent lymphoid malignancies. Its antineoplastic mechanisms involve inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool for cancer research. This compound is suitable for studies aimed at understanding the therapeutic potential of purine analogs in oncology. -
Adenosine Analog
N6-(4-Methoxybenzyl)adenosine is an adenosine analog that primarily acts as a smooth muscle vasodilator. This compound has demonstrated potential in inhibiting cancer progression, making it valuable for research in oncology and cardiovascular studies. Its unique structure enables investigations into adenosine signaling pathways and their implications in various biological processes. -
Adenosine Analog
N6-Benzoyl-2'-fluoro-2'-deoxyarabinoadenosine is an adenosine analog that primarily targets adenosine receptors. It exhibits significant vasodilatory effects on smooth muscle and has demonstrated potential in inhibiting cancer progression. This compound is valuable in research focused on vascular biology and cancer therapeutics, offering insights into adenosine receptor signaling pathways and their clinical implications. -
Purine Nucleoside Analog
2’-C-β-Methyl-4-deoxyuridine is a purine nucleoside analogue that inhibits DNA synthesis and induces apoptosis. This compound exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. It is valuable in cancer research applications aimed at understanding the mechanisms of action of nucleoside analogues in tumor cell proliferation and survival. -
Purine Nucleoside Analog
2’-β-C-Methyl-5-fluorouridine is a purine nucleoside analog known for its antitumor properties. This compound exhibits significant biological activity by inhibiting DNA synthesis and inducing apoptosis, making it particularly valuable for the study of indolent lymphoid malignancies. Its applications extend to cancer research, where it can be utilized to explore therapeutic strategies and mechanisms underlying tumor progression. -
Purine Nucleoside Analog
2-Amino-2′-C-methyladenosine is a purine nucleoside analog that exhibits significant antitumor activity, specifically targeting indolent lymphoid malignancies. Its anticancer mechanisms involve the inhibition of DNA synthesis and the induction of apoptosis. This compound serves as a valuable tool in cancer research, providing insights into therapeutic strategies for lymphoid malignancies. -
Pyrimidine Nucleoside Analog
Methyl 1,2,3,4-tetrahydro-α-hydroxy-2,4-dioxo-1-β-D-ribofuranosyl-5-pyrimidineacetate is a pyrimidine nucleoside analog that targets nucleic acid synthesis pathways. This compound exhibits significant activities, including the inhibition of DNA and RNA synthesis, as well as antiviral and immunomodulatory effects. It is a valuable tool in the study of biochemical processes and the development of therapeutic agents in cancer and viral research. -
Purine Nucleoside Analog
6-Chloro-9-(3,5-di-O-acetyl-2-O-methyl-β-D-ribofuranosyl)-9H-purine is a purine nucleoside analog that targets nucleic acid synthesis. This compound exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its anticancer mechanisms primarily involve the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable reagent for cancer research and therapeutic studies. -
Purine Nucleoside Analog
2′-Amino-5′-O-[bis(4-methoxyphenyl)phenylmethyl]-2′-deoxyuridine is a purine nucleoside analog. It exhibits significant antitumor activity, particularly against indolent lymphoid malignancies, through mechanisms such as inhibition of DNA synthesis and induction of apoptosis. This compound is valuable for research applications focused on cancer biology and therapeutic development for hematological malignancies. -
Cytidine Analog
N4-Methylarabinocytidine is a cytidine nucleoside analog that inhibits DNA methyltransferases, thereby affecting DNA methylation processes. This compound exhibits potential anti-metabolic and anti-tumor activities, making it valuable for cancer research and studies on epigenetic regulation. Its role as a nucleoside analog provides a tool for exploring the mechanisms of DNA modification and gene expression control in various biological contexts. -
Purine Nucleoside Analog
5-(Furan-2-yl)-2'-O-methyl-5'-O-DMTr-uridine is a purine nucleoside analog designed to interfere with DNA synthesis and induce apoptosis in malignant cells. This compound exhibits broad antitumor activity, particularly against indolent lymphoid malignancies, making it a valuable tool in cancer research. Its unique structural modifications enhance its efficacy as a pharmacological agent in studying cancer-related pathways and therapeutic interventions. -
Purine Nucleoside Analog
9-(3-Deoxy-3-fluoro-β-D-ribofuranosyl)-6-(furan-2-yl)purine functions as a purine nucleoside analog. It exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. The compound's mechanisms of action include the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool for cancer research and therapeutic development. -
Cytidine Analog
1-(β-D-Xylofuranosyl)-5-methylcytosine is a cytidine analog that functions primarily as an inhibitor of DNA methyltransferases. This compound exhibits potential anti-metabolic and anti-tumor activities, making it a valuable tool in epigenetics research. It is suitable for studies investigating the role of DNA methylation in gene regulation and cancer biology. -
Purine Nucleoside Analog
3’-Azido-3’-deoxy-2-thiouridine is a purine nucleoside analog that exhibits significant anticancer activity primarily through the inhibition of DNA synthesis and the induction of apoptosis. This compound is particularly effective against indolent lymphoid malignancies, making it a valuable tool in cancer research. Additionally, it serves as a click chemistry reagent, featuring an azide group that allows for copper-catalyzed azide-alkyne cycloaddition (CuAAc) and strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with alkyne-containing molecules. -
Purine Nucleoside Analog
5'-O-Triphenylmethyl-2'-deoxyuridine is a purine nucleoside analog recognized for its ability to inhibit DNA synthesis and induce apoptosis. This compound demonstrates significant antitumor activity, particularly against indolent lymphoid malignancies. It serves as a valuable tool for researchers exploring therapeutic strategies in cancer treatment and mechanisms of nucleoside analogs in oncology. -
Purine Nucleoside Analog
N4-Benzoyl-2'-O-(2-methoxyethyl)cytidine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. This compound functions by inhibiting DNA synthesis and inducing apoptosis in cancer cells. Research applications include studying its effects on cellular proliferation and evaluating its potential in cancer therapy. -
Purine Nucleoside Analog
8-Hydroxy-xyloguanosine is a purine nucleoside analog that demonstrates significant antitumor activity, particularly against indolent lymphoid malignancies. Its anticancer mechanisms involve the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool for cancer research. This compound is suitable for studies aimed at elucidating the roles of purine metabolism in cancer biology and exploring potential therapeutic applications. -
Purine Nucleoside Analog
2’-β-C-Ethynyladenosine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its mechanisms include the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool in cancer research. Additionally, this compound features an alkyne group, enabling its use in click chemistry applications through copper-catalyzed azide-alkyne cycloaddition (CuAAc) with azide-containing molecules. -
Purine Nucleoside Analog
Uridine-5-oxyacetic acid is a purine nucleoside analog that exhibits broad antitumor activity, particularly against indolent lymphoid malignancies. Its mechanisms of action include the inhibition of DNA synthesis and induction of apoptosis, making it a valuable tool in cancer research. This compound is useful for studies aimed at understanding the therapeutic potential of purine analogs in oncological applications. -
Purine Nucleoside Analog
4′,5′-Didehydro-5′-deoxy-2′-O-methyluridine is a purine nucleoside analog that exhibits significant antitumor activity against indolent lymphoid malignancies. Its biological activity is primarily attributed to mechanisms such as the inhibition of DNA synthesis and the induction of apoptosis. This compound serves as a valuable tool for researchers investigating cancer treatment and the underlying biology of nucleoside analogs in therapeutic applications. -
Purine Nucleoside Analog
5-Methoxy-4-thiouridine is a purine nucleoside analog that exhibits significant antitumor activity against indolent lymphoid malignancies. Its anticancer mechanisms involve the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable compound for research in cancer biology. This reagent is useful for studies exploring the effects of nucleoside analogs on cellular proliferation and programmed cell death. -
Purine Nucleoside Analog
N6-Isopentenyl-2’-deoxy adenosine, also known as 2’-deoxy riboprine, is a purine nucleoside analog that primarily targets DNA synthesis inhibition. This compound exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its anticancer effects are attributed to mechanisms such as the induction of apoptosis and disruption of cell proliferation, making it a valuable reagent for cancer research applications. -
Purine Nucleoside Analog
5-Methyl-4-thiouridine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its anticancer mechanisms involve the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool for research in cancer therapeutics and cell proliferation studies. This compound is useful for investigating the effects of purine metabolism and nucleoside analogs in various biological contexts. -
Purine Nucleoside Analog
3′-Deoxy-3′-methylcytidine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its primary mechanisms involve the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool in cancer research. This compound is suitable for studies aimed at understanding the molecular underpinnings of cancer and evaluating potential therapeutic strategies. -
Purine Nucleoside Analog
5'-Deoxy-5-methyluridine is a purine nucleoside analog known for its significant antitumor activity, particularly against indolent lymphoid malignancies. Its mechanism of action primarily involves the inhibition of DNA synthesis and the induction of apoptosis in cancer cells. This compound is valuable in research aimed at elucidating mechanisms of cancer progression and developing novel therapeutic strategies. -
Adenosine Analog
2'-Chloro-N6-benzyl adenosine is a chemically modified adenosine analog. This compound primarily functions as a smooth muscle vasodilator and exhibits potential inhibitory effects on cancer progression. Its unique structural properties make it a valuable tool for research in vascular biology and oncology, facilitating studies on adenosine signaling pathways and their implications in various physiological and pathological conditions. -
Purine Nucleoside Analog
7-n-Propyl-7,8-dihydro-8-oxo-9-(β-D-xylofuranosyl)guanine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its primary mechanism involves the inhibition of DNA synthesis, leading to the induction of apoptosis in susceptible cancer cells. This compound serves as a valuable tool in cancer research, facilitating the exploration of therapeutic strategies targeting purine metabolism and cell proliferation. -
Purine Nucleoside Analog
3’-O-MOE-5MeU-2’-phosphoramidite is a purine nucleoside analog that serves as a key reagent in nucleic acid synthesis. This compound demonstrates significant antitumor activity, particularly against indolent lymphoid malignancies, through mechanisms including the inhibition of DNA synthesis and the induction of apoptosis. Its utility in research includes applications in the development of therapeutic agents and the study of nucleic acid interactions. -
Purine Nucleoside Analog
2’-Deoxy-N4-ethyl-5-methylcytidine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. This compound functions by inhibiting DNA synthesis and inducing apoptosis, thereby disrupting the proliferation of cancer cells. It serves as a valuable tool in cancer research, aiding in the study of nucleoside analog mechanisms and potential therapeutic applications. -
Purine Nucleoside Analog
3’-Deoxy-methyl-2-thiouridine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its mechanism of action primarily involves the inhibition of DNA synthesis and the induction of apoptosis in cancer cells. This compound is valuable for research applications in cancer biology, enabling the exploration of therapeutic strategies targeting DNA replication and cellular survival pathways. -
Adenosine Analog
2-Amino-6-chloro-9-[(2,3,5-tri-O-benzoyl-2-C-Methyl-beta-D-ribofuranosyl)]-9H-purine is an adenosine analog that primarily targets adenosine receptors. This compound exhibits biological activities such as promoting smooth muscle vasodilation and potentially inhibiting cancer progression. It is a valuable reagent for researchers investigating vascular biology, cancer therapeutics, and adenosine signaling pathways. -
Purine Nucleoside Analog
7-Ethyl-7,8-dihydro-8-oxo-9-(β-D-xylofuranosyl)guanine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its mechanism of action involves the inhibition of DNA synthesis and the induction of apoptotic pathways. This compound serves as a valuable tool in cancer research, facilitating studies on therapeutic strategies targeting nucleoside metabolism and cancer cell proliferation. -
Purine Nucleoside Analog
N6-iso-Propyladenosine is a purine nucleoside analog with significant antitumor activity, particularly against indolent lymphoid malignancies. Its primary mechanisms include inhibition of DNA synthesis and induction of apoptosis, making it a valuable tool in cancer research. This compound is useful for studying the effects of nucleoside analogs on cellular proliferation and apoptosis in various cancer models. -
Adenosine Analog
2-Amino-N-(3-methyl-2-buten-1-yl)adenosine is an adenosine analog that primarily targets adenosine receptors. This compound exhibits significant smooth muscle vasodilatory activity and has been implicated in the inhibition of cancer progression. It serves as a valuable tool for research in vascular biology and cancer therapeutics, facilitating the exploration of adenosine receptor signaling pathways and their implications in various disease states. -
Purine Nucleoside Analog
1,4-Anhydro-2,3-O-isopropylidene-5-O-t-butyldiphenylsilyl-4-thio-D-ribitol is a purine nucleoside analog that exhibits potent antitumor activity. This compound acts primarily by inhibiting DNA synthesis and inducing apoptosis, making it a valuable tool in the study of indolent lymphoid malignancies. Its ability to mimic natural nucleosides allows for exploration in cancer research and therapeutic development. -
Purine Nucleoside Analog
DMTr-TNA-C(Bz)-amidite is a purine nucleoside analog that serves as a critical component in nucleic acid synthesis. This compound exhibits broad antitumor activity, particularly against indolent lymphoid malignancies. Its mechanisms of action include the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable reagent for cancer research applications focused on therapeutic development and molecular studies. -
Purine Nucleoside Analog
N6-Methyl-2-methyl thioadenosine is a purine nucleoside analog that serves as a promising reagent in cancer research. This compound exhibits significant antitumor activity, particularly against indolent lymphoid malignancies, by inhibiting DNA synthesis and inducing apoptosis. Its mechanisms of action make it valuable for studying therapeutic strategies in oncology. -
Purine Nucleoside Analog
7,8-Dihydro-8-oxo-7-propargyl-3’-deoxy-3’-fluoro-xylo-guanosine is a purine nucleoside analog that demonstrates significant antitumor activity, particularly against indolent lymphoid malignancies. Its mechanisms of action include the inhibition of DNA synthesis and the induction of apoptosis. Additionally, this compound serves as a click chemistry reagent, featuring an alkyne group that can participate in copper-catalyzed azide-alkyne cycloaddition (CuAAc) with azide-containing molecules, expanding its utility in chemical biology and drug development research. -
Purine Nucleoside Analog
5'-Azido-2',5'-dideoxyuridine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its mechanisms of action include the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool for cancer research. This compound is utilized for studying the effects of nucleoside analogs in cellular and molecular contexts related to oncogenesis and therapeutic resistance. -
Purine Nucleoside Analog
9-(2,3,5-Tri-O-benzoyl-2-C-methyl-β-D-ribofuranosyl)-9H-purin-2-amine is a purine nucleoside analog that exhibits broad antitumor activity, particularly against indolent lymphoid malignancies. This compound impedes DNA synthesis and promotes apoptosis, contributing to its efficacy in cancer therapeutics. It is a valuable tool in research focused on understanding cancer biology and developing novel treatment strategies. -
Purine Nucleoside Analog
2-Amino-N,N-dimethyl-2′-C-methyladenosine is a purine nucleoside analog with significant biological activity against indolent lymphoid malignancies. Its mechanisms of action include the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool for cancer research. This compound can be utilized in studies aiming to elucidate the therapeutic potentials of nucleoside analogs in oncology.
